Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for FRMM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 4.102M
March 31, 2026 65.90M
December 31, 2025 9.034M
September 30, 2025 558.90M
June 30, 2025 2.218M
March 31, 2025 3.724M
December 31, 2024 4.567M
September 30, 2024 0.1949M
June 30, 2024 1.146M
March 31, 2024 0.676M
December 31, 2023 1.976M
September 30, 2023 2.662M
June 30, 2023 2.009M
March 31, 2023 2.646M
December 31, 2022 6.970M
September 30, 2022 3.589M
June 30, 2022 1.625M
March 31, 2022 5.669M
December 31, 2021 8.224M
Date Value
September 30, 2021 11.69M
June 30, 2021 1.836M
March 31, 2021 6.053M
December 31, 2020
September 30, 2020 0.6529M
June 30, 2020 1.046M
March 31, 2020 0.2834M
December 31, 2019 0.5466M
September 30, 2019 0.836M
June 30, 2019 0.1103M
March 31, 2019 0.1346M
December 31, 2018 0.2709M
September 30, 2018 0.5191M
June 30, 2018 0.5431M
March 31, 2018 0.3401M
December 31, 2017 0.4284M
September 30, 2017 0.4535M
June 30, 2017 0.5776M
March 31, 2017 0.0672M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Abeona Therapeutics, Inc. 146.83M
Corcept Therapeutics, Inc. 308.20M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B
Anika Therapeutics, Inc. 38.41M